Terumo Stock

JPY2,436.50

0.23% today

Tokyo, Jul 16, 08:15 am CET

ISIN

JP3546800008

Symbol

4543

Index

Nikkei 225

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Terumo Stock price

JPY2,442.00

+439.00 21.92% 5Y

Tokyo, Closing price Tue, Jul 15 2025

-3.50 0.14%

ISIN

JP3546800008

Symbol

4543

Index

Nikkei 225

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

JPY3.6t

Enterprise Value

JPY3.6t

Net debt

positive

Cash

JPY222.3b

Shares outstanding

1.5b

Valuation (TTM | estimate)

P/E

30.8 | 23.6

P/S

3.5 | 3.3

EV/Sales

3.4 | 3.3

EV/FCF

27.8

P/B

2.6

Dividends

DPS

JPY30.00

Yield 1Y | 5Y

1.2% | 1.0%

Growth 1Y | 5Y

15.4% | 15.7%

Payout 1Y | 3Y

32.9% | 32.4%

Increased

7 Years

Financials (TTM | estimate)

Revenue

JPY1.0t | JPY1.1t

EBITDA

JPY243.1b | JPY282.8b

EBIT

JPY157.7b | JPY191.9b

Net Income

JPY117.0b | JPY153.1b

Free Cash Flow

JPY128.4b

Growth (TTM | estimate)

Revenue

12.4% | 6.5%

EBITDA

12.1% | 16.3%

EBIT

12.5% | 21.7%

Net Income

10.0% | 30.9%

Free Cash Flow

90.1%

Financial Health

Equity Ratio

74.9%

Return on Equity

8.6%

ROCE

9.9%

ROIC

8.5%

Debt/Equity

0.1

EPS

JPY79.3

FCF per Share

JPY87.1

Short interest

Employees

28k

Rev per Employee

JPY36.6m

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Get Started for Free Today

Terumo Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Terumo forecast:

16x Buy

76%

5x Hold

24%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Terumo forecast:

Buy

76%

Hold

24%

Analyst Estimates with Stock Price Targets

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	1,036,171 1,036,171	12% 12% 100%
- Direct Costs	475,501 475,501	8% 8% 46%
Gross Profit	560,670 560,670	17% 17% 54%
- Selling and Administrative Expenses	381,648 381,648	11% 11% 37%
- Research and Development Expense	- -	- -
EBITDA	243,117 243,117	12% 12% 23%
- Depreciation and Amortization	85,449 85,449	11% 11% 8%
EBIT (Operating Income) EBIT	157,668 157,668	13% 13% 15%
Net Profit	116,978 116,978	10% 10% 11%

In millions JPY.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office	Japan
CEO	Hikaru Samejima
Employees	28,294
Founded	1921
Website	www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now